Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.
OBJECTIVE
Diffusion-weighted magnetic resonance imaging (DWI) and fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) are oncological feasible techniques. Currently, apparent diffusion coefficient (ADC) measured by DWI and standard uptake value (SUV) from FDG PET/CT have similar applications in clinical oncology. The aim of this study was to assess the correlation between ADC and SUV in primary cervical cancer.


METHODS
Patients with documented primary cervical cancer were recruited. All participants underwent abdominopelvic DWI at 3T and FDG PET/CT within 2 weeks. For the primary tumor, ADC was measured as minimum ADC (ADC(min)) and mean ADC (ADC(mean)) within the whole tumor by DWI. Maximum SUV (SUV(max)) and mean SUV (SUV(mean)) were measured by FDG PET/CT.


RESULTS
A total of 33 patients were included. There was no significant correlation either between ADC(min) and SUV(max) or between ADC(mean) and SUV(mean). The relative ADC(min) (rADC(min)) defined as ADC(min)/ADC(mean) ratio was significantly inversely correlated with the relative SUV(max) (rSUV(max)) defined as SUV(max)/SUV(mean) ratio (r = -0.526, P = 0.0017) in all study patients. A significantly inverse correlation between rADC(min) and rSUV(max) was observed in patients with adenocarcinoma/adenosquamous carcinoma (r = -0.685, P = 0.0012) and those with well-to-moderate differentiated tumor (r = -0.631, P = 0.0050). No significant correlation was demonstrated in patients with squamous cell carcinoma or poorly differentiated tumor.


CONCLUSIONS
The significantly inverse correlation between rADC(min) and rSUV(max) in primary cervical tumor suggests that DWI and FDG PET/CT might play a complementary role for the clinical assessment of this cancer type.
Ho
Kung-Chu
KC
Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital and Chang Gung University, 5 Fu-Shin Street, Kueishan, Taoyuan, 333, Taiwan.
Lin
Gigin
G
Wang
Jiun-Jie
JJ
Lai
Chyong-Huey
CH
Chang
Chee-Jen
CJ
Yen
Tzu-Chen
TC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004058:Diffusion; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000378:metabolism*
D019788:Fluorodeoxyglucose F18
Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):493-501
17955238
Eur J Nucl Med. 1996 Oct;23(10):1372-7
8781143
Neuroradiology. 2006 Sep;48(9):622-31
16752135
Radiology. 2007 May;243(2):493-9
17356177
J Nucl Med. 1998 Oct;39(10):1727-35
9776278
Gynecol Oncol. 2006 Apr;101(1):147-51
16263155
Clin Cancer Res. 2000 Oct;6(10):3837-44
11051227
Semin Nucl Med. 2006 Jan;36(1):93-104
16356798
J Nucl Med. 2007 Jun;48(6):932-45
17504879
J Exp Clin Cancer Res. 2004 Mar;23(1):39-45
15149149
Radiology. 2002 Jul;224(1):177-83
12091680
Magn Reson Imaging. 1997;15(7):771-84
9309608
Magn Reson Imaging Clin N Am. 2007 Aug;15(3):433-48, viii
17893061
Neuroimage. 2007 Feb 15;34(4):1588-99
17188516
Hematol Oncol. 2006 Sep;24(3):146-50
16729353
J Magn Reson Imaging. 2006 Aug;24(2):319-24
16786565
Ann Nucl Med. 2007 Jun;21(4):209-15
17581719
Magn Reson Imaging. 2006 Sep;24(7):843-7
16916701
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16759-64
16267128
Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1639-47
12458399
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):353-9
12023139
J Clin Oncol. 2006 Dec 20;24(36):5687-94
17179104
AJNR Am J Neuroradiol. 2007 Oct;28(9):1693-9
17885229
Semin Nucl Med. 2008 Mar;38(2):141-8
18243850
J Nucl Med. 2006 Nov;47(11):1808-12
17079814
AJNR Am J Neuroradiol. 2007 Jun-Jul;28(6):1088-92
17569964
J Clin Oncol. 2007 Sep 10;25(26):4104-9
17827460
J Clin Oncol. 2002 Jan 15;20(2):379-87
11786564
AJNR Am J Neuroradiol. 2007 Sep;28(8):1547-51
17846209
Radiology. 2006 Dec;241(3):839-46
17032910
Nat Rev Cancer. 2008 Feb;8(2):94-107
18202697
J Magn Reson Imaging. 2006 Feb;23(2):130-4
16374882
Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):960-71
17141979
Radiology. 2007 Dec;245(3):806-13
17911539
Radiology. 2007 Nov;245(2):491-8
17940305
J Nucl Med. 2007 Jan;48 Suppl 1:68S-77S
17204722
Nat Clin Pract Oncol. 2008 Apr;5(4):220-33
18301415
Magn Reson Med Sci. 2005 Dec 31;4(4):175-86
16543702
Eur J Radiol. 2003 Mar;45(3):208-13
12595105
J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):49-56
17296704
Eur Radiol. 2005 Jan;15(1):71-8
15538578
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5524-9
15805192
AJNR Am J Neuroradiol. 2006 Aug;27(7):1419-25
16908550
Radiology. 2007 May;243(2):570-7
17400757
Radiology. 2006 Apr;239(1):122-30
16493012
J Nucl Med. 2004 Sep;45(9):1431-4
15347707
J Magn Reson Imaging. 2008 Jul;28(1):128-35
18581404
Invest Radiol. 2007 Sep;42(9):605-13
17700275
Radiology. 2001 Sep;220(3):621-30
11526259
Nat Med. 2008 Apr;14(4):459-65
18376410
Radiology. 2008 May;247(2):458-64
18430878
Radiology. 2003 Jun;227(3):731-8
12702828
JAMA. 2007 Nov 21;298(19):2289-95
18029833